Mandate

Vinge advises Intrum in connection with its EUR 450m bond issuance

Vinge advises Intrum AB (publ) in connection with its issuance of senior secured fixed rate bonds in an amount of EUR 450 million.

The proceeds will be used to refinance, in part, Intrum’s 3.125% Senior Notes due 2024, and the bonds will be listed on the Securities Official List of the Luxembourg Stock Exchange. The bonds have a tenor of five years and were issued with a coupon of 9.25 per cent and at a price of 97.020% of the nominal amount.

Vinge’s team consisted of Louise Brorsson Salomon, Lionardo Ojeda, Jolinn Uhlin, Calle Tengwall Pagels (Banking and Finance), Victor Ericsson and Maja Prahl (Tax)

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026